The Third People's Hospital of Zhenjiang
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tan, Youwen
NCT05115942: Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

Completed
3
248
RoW
Hydronidone capsules, F351, The placebo capsules, N
Beijing Continent Pharmaceutical Co, Ltd.
Liver Fibrosis
10/24
10/24
NCT05905172: Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

Recruiting
3
248
RoW
Hydronidone capsules, F351, The placebo capsules, N
Beijing Continent Pharmaceutical Co, Ltd.
Liver Fibrosis
06/28
10/28
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C

Recruiting
2/3
520
RoW
HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo
Sunshine Lake Pharma Co., Ltd.
Chronic HCV Infection
04/23
04/23
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

Completed
2
250
RoW
GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table
Sunshine Lake Pharma Co., Ltd.
Chronic HBV Infection
06/22
09/23
CHESS1901, NCT03990753: Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (/APPHA1901)

Recruiting
N/A
1000
RoW
esophagogastroduodenoscopy
Nanfang Hospital of Southern Medical University, Southern Medical University, China, LanZhou University, Zhongda Hospital, Medical School, Southeast University, Guangdong Second Provincial General Hospital, Xingtai People's Hospital, The Third Hospital of Zhenjiang Affiliated Jiangsu University, Tianjin Second People's Hospital, Zhejiang University Lishui Hospital, The Second Hospital of Anhui Medical University, The Sixth People's Hospital of Shenyang, Xi'an Gaoxin Hospital, King Chulalongkorn Memorial Hospital affiliated to Chulalongkorn University, Ankara University
Compensated Cirrhosis
06/21
06/22
Wen, Tan You
NCT05896124: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Recruiting
2
75
RoW
2mg CS0159, Placebo
Cascade Pharmaceuticals, Inc
Primary Biliary Cholangitis (PBC)
10/24
10/24

Download Options